The CD11c/CD3 baseline ratio was 0.75 (95% CI 0.52–0.98) in the tumor compartment, 0.44 (95% CI 0.17–0.71) in the stromal compartment, and 0.58 (95% CI 0.29–0.87) in the total tumor (Table 1). The gene discussed is ITGAX; the disease is neoplasm.